Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
Date:8/1/2013

wan. Arena plans to enter into additional collaborations to commercialize BELVIQ outside of these territories.

About Arena PharmaceuticalsArena is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ® (lorcaserin HCl), Arena's internally discovered drug, is approved in the United States and is under review for regulatory approval in additional territories. Arena's US operations are located in San Diego, California, and its operations outside of the United States, including its commercial manufacturing facility, are located in Zofingen, Switzerland. For more information, visit Arena's website at www.arenapharm.com.

Arena Pharmaceuticals® and Arena® are registered service marks of Arena Pharmaceuticals, Inc. BELVIQ® is a registered trademark of Arena Pharmaceuticals GmbH.

Forward-Looking Statements Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the advancement, therapeutic indication and use, safety, efficacy, mechanism of action, regulatory review and approval, and potential of BELVIQ; opportunity provided by BELVIQ, including in the medical management of patients; research and development relating to BELVIQ, including in combination with phentermine and related plans; rights and obligations under the marketing and supply agreement with CYB; the therapeutic indication, safety and efficacy of APD811 and APD334 and related expectations; plans to enter into additional collaborations and related strategy; and Arena's focus, plans, goals, strategy, expectations, research and development programs, and ability to discover and develop compounds and commercialize drugs. For such statemen
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
2. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
3. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
4. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
5. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
6. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
9. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
10. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
11. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... South Korea , Aug. 28, 2015 ... National University and Dr. Ra from Biostar , ... , Confirmed 30% increase of lifespan through multiple IV ... function, physical vitality, and life expectancy found , ... in Korea have determined the possibility that adult mesenchymal ...
(Date:8/28/2015)... LONDON , August 28, 2015 ... approach seamlessly connects people, technologies and care protoc ... improving outcomes and the cost of healthcare delivery   ... PHIA) today announced its presence at  ESC Congress 2015 , where ... Model A.I. , EchoNavigator and IntelliSpace Cardiovascular, that connect people ...
(Date:8/27/2015)... , Aug. 27, 2015  A recent ... KSSTA Knee Journal, compared the Arthrosurface HemiCAP® Wave ... design, versus an "onlay" design implant for isolated ... improvements in function and pain scores, none of ... of osteoarthritis (OA). However, 53% of the patients ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... JUPITER, Fla., March 7, 2011 Dyadic International, Inc. ... that it will release financial results for the year ... before market open to be followed by a conference ... http://photos.prnewswire.com/prnh/20091214/DYADICLOGO) The conference call may be accessed ...
... Boston Scientific Corporation (NYSE: BSX ) ... its OMEGA™ Platinum Chromium Bare-Metal Coronary Stent System, ... Boston Scientific,s unique platinum chromium (PtCr) alloy designed ... provide interventional cardiologists with a bare-metal stent with ...
Cached Medicine Technology:Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 2Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 3Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System 4
(Date:8/28/2015)... ... 28, 2015 , ... Popular review site Top5MillionaireDatingSites.com recently published ... . According to the listings, MillionaireMatch.com bags the top spot while ... spokesperson of Top5MillionaireDatingSites.com said, “This website has been designed to assist ...
(Date:8/28/2015)... Livermore, CA (PRWEB) , ... August 28, 2015 , ... ... annual Inc. 5000 list, an exclusive ranking of the nation’s fastest-growing private companies. The ... list’s history. With sales growth of 85% over the last three years, PREVENT ranks ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... through health promotion and disease prevention, improving a patient’s quality of life through ... the community, including heart disease, cancer, diabetes, HIV/AIDS, STDs, and others. A Women’s, ...
(Date:8/27/2015)... , ... August 28, 2015 , ... This new webinar ... that patients are always scheduled for the next visit, their authorizations are in check, ... . , According to Jason Barnes, COO for Genesis Chiropractic Software, growing a practice ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... average annual cost to treat a patient with hemophilia is $175,000. Hemophilia is ... a cure and improving treatment. The RMHBDA exists to help raise funds for ...
Breaking Medicine News(10 mins):Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2Health News:Health Clinic Opening and Public Art Unveiling 2Health News:A New Webinar Teaches Chiropractors How to Use Compliance Alerts to Manage Patient Relationships 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4
... ... Collaboration for a New Century (The Collaboration) announced today the availability ... program called savingsdrugcard.com provides a free drug card that will help ... download this card by visiting http://www.SavingsDrugCard.com and can immediately ...
... trouble , TUESDAY, July 7 (HealthDay News) -- Drugs commonly ... heartburn. , A new study in the July issue of ... inhibitor (PPI) actually produced heartburn, acid reflux and indigestion in ... , Although the findings don,t necessarily mean that PPIs don,t ...
... KAMPALA, Uganda and NAIROBI, Kenya and DELHI, India, July 7 ... the International Treatment Preparedness Coalition (ITPC) calls on leaders of ... ensure that AIDS treatment and prevention programs for millions of ... the economic down-turn. , , "Cutting funds for ...
... 2009 Dr. Nima Sharifi, assistant professor of internal medicine ... Medical Institute Early Career Physician-Scientist Award. He is one ... institute to be part of the program, which is aimed ... discoveries into improved treatment for patients. Established in 2006, the ...
... LONDON, July 7 IBM (NYSE: IBM ) ... technical expertise in innovative ways to address the greatest societal challenges ... Awards for Excellence yesterday. , , (Logo: ... the award for World Community Grid , in ...
... ... Ky. and a 22-year veteran of Quorum Health Resources (QHR), the nation,s largest hospital management ... , ... 7, 2009 -- Terry Peeples, CEO of Jennie Stuart Medical Center in Hopkinsville, ...
Cached Medicine News:Health News:Popular Prescription Drug Discount Card Now Available in Arizona Online 2Health News:Popular Prescription Drug Discount Card Now Available in Arizona Online 3Health News:Heartburn Drugs May Contribute to the Problem 2Health News:Heartburn Drugs May Contribute to the Problem 3Health News:World Financial Crisis and AIDS Backlash Threaten Lives 2Health News:World Financial Crisis and AIDS Backlash Threaten Lives 3Health News:UT Southwestern researcher named HHMI Early Career Physician-Scientist 2Health News:IBM Award for Innovative Solution to Tackling World's Most Critical Social and Environmental Problems 2Health News:IBM Award for Innovative Solution to Tackling World's Most Critical Social and Environmental Problems 3Health News:IBM Award for Innovative Solution to Tackling World's Most Critical Social and Environmental Problems 4Health News:IBM Award for Innovative Solution to Tackling World's Most Critical Social and Environmental Problems 5Health News:QHR Associate Named Chair of Kentucky Hospital Association Board of Trustees 2
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
... Tm Bioscience introduces the Tag-It™ Cystic ... for cystic fibrosis genotyping. With validated performance ... assay will provide superior mutation coverage for ... aid to diagnosis in newborns. ,The ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: